Efficacy of pap test in combination with thinprep cytological test in screening for cervical cancer

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 4, 2012, Pages 1651-1655

  Chen, Hua ^a   Shul, Hui Min ^a   Chang, Zhou Lin ^a   Wang, Zhi Feng ^a   Zhu, Hong Mei ^a   Lu, Tian Mei ^a   Ma, Qiang Yan ^a   Yang, Bin Lie ^b  

^a Department of Otolaryngology Gong li Hospital   (China)

^b People's Hospital of Pudong New Area   (China)

Author keywords

Cervical cancer; China; pap test; screening method; ThinPrep cytological test; Youden index

Indexed keywords

ADULT; AGED; ARTICLE; BIOPSY; CHINA; COLPOSCOPY; CYTODIAGNOSIS; EARLY DIAGNOSIS; FEMALE; HUMAN; LABORATORY DIAGNOSIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CHINA; COLPOSCOPY; CYTODIAGNOSIS; EARLY DETECTION OF CANCER; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84870635563     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.4.1651     Document Type: Article

References (23)

1. Abulafia O, Pezzullo JC, Sherer DM (2003). Perfomance of Thinprep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears :a quantitative survey. Gynecol Oncol, 90, 137-44.
2. American Cancer Society. Cervical Cancer. 2008. Available at: http://www.cancer.org/acs/groups/cid/documents/ webcontent/003094-pdf.
3. Belinson J, Qiao Y, Pretorius R, et al (1999). Prevalence of cervical cancer and feasibility of screening in rural China: a pilot study for the Shanxi Province Cervical Cancer Screening Study. Int J Gynecol Cancer, 9, 411-7.
4. Belinson J, Qiao YL, Pretorius R, et al (2001). Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol, 83, 439-44.
5. Belinson JL, Pan QJ, Biscotti C, et al (2002). Primary screening with liquid-based cytology in an unscreened population in rural China, with an emphasis on reprocessing unsatisfactory samples. Acta Cytol, 46, 470-4.
6. Bian ML, Chen QY, Liu J, et al (2004). A comparison of cytology and cervicography in cervical cancer screening. J China- Japan Friendship Hospital, 18, 323-52.
7. Cao ZY (2002). Chinese Obstetrics and Gynecology. 1st ed. Beijing: People's Health Publisher, 1747.
8. Carns B, Fadare O (2008) Papanicolaou test in the detection of high-grade cervical lesions: a re-evaluation based on cytohistologic non-correlation rates in 356 concurrently obtained samples. Int J Clin Exp Pathol, 1, 285-90.
9. Fahey MT, Irwig L, Macaskill P (1995). Meta-analysis of Pap test accuracy. Am J Epidemiol, 141, 680-9.
10. Goldie SJ, Grima D, Kohli M, et al (2003). A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. Int J Cancer, 106, 896-904.
11. Guo M, Hu L, Martin L, et al (2005). Accuracy of liquid-based Pap tests: comparison of concurrent liquid-based test and cervical biopsies on 782 women with previously abnormal Pap smears. Acta Cytol, 49, 55-6.
12. Li J, Kang LN, Qiao YL (2011). Review of the cervical cancer disease burden in mainland china. Asian Pac J Cancer Prev, 12, 1149-53.
13. Li N, Shi JF, Franceschi S, et al (2009). Different cervical cancer screening approaches in a Chinese multicentre study. Br J Cancer, 100, 532-37.
14. Ling L, Sun H, Chen W (2004). Role of cervical smear and colposcopy in general gynecological screening. Shanghai J Prevent Med, 16, 351-2.
15. Pan Q, Belinson JL, Li L, et al (2003). A thin-layer, liquidbased Pap test for mass screening in an area of China with a high incidence of cervical carcinoma A cross-sectional, comparative study. Acta Cytol, 47, 45-50.
16. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Gobal cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
17. Ruopp MD, Perkins NJ, Whitcomb BW, Schisterman EF (2008). Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection. Biom J, 50, 419-30.
18. Shi JF, Canfell K, Lew JB, et al (2011). Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study. BMC Cancer, 11, 239.
19. Shi JF, Canfell K, Lew JB, Qiao YL (2012). The burden of cervical cancer in China: Synthesis of the evidence. Int J Cancer, 130, 6541-2.
20. Thrall MJ, Pambuccian SE, Stelow EB, et al (2008). Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria. Cancer, 114, 171-9.
21. Tu JH, Zhong YC, Di W, et al (2008). Value of cervical cytologic tests and colposcopy in diagnosis of cervical lesions. J Shanghai Jiaotong University (Medical Science), 28, 318-31.
22. Weintraub NT, Violi E, Freedman ML (1987). Cervical cancer screening in women aged 65 and over. J Am Geriatr Soc, 35, 870-5.
23. Yang L, Parkin DM, Ferlay J, Li L, Chen Y (2005). Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev, 14, 243-50.